Picture of Centene logo

CNC Centene Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapNeutral

Annual cashflow statement for Centene, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line1,3361,2022,6993,294-6,677
Depreciation
Deferred Taxes
Non-Cash Items1491,9437651217,512
Unusual Items
Other Non-Cash Items
Changes in Working Capital1,3762,1783,324-4,5152,900
Change in Accounts Receivable
Change in Other Assets
Change in Payable / Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities4,2056,2458,0031544,950
Capital Expenditures-910-1,004-799-644-767
Purchase of Fixed Assets
Other Investing Cash Flow Items-2,389-1,917-392-4081,239
Acquisition of Business
Sale of Business
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-3,299-2,921-1,191-1,052472
Financing Cash Flow Items-174-41-88-6-38
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities1,362-4,197-1,658-2,406-1,621
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash2,257-8845,122-3,2963,801